1. Home
  2. TRSG vs XLO Comparison

TRSG vs XLO Comparison

Compare TRSG & XLO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • TRSG
  • XLO
  • Stock Information
  • Founded
  • TRSG 1996
  • XLO 2016
  • Country
  • TRSG Singapore
  • XLO United States
  • Employees
  • TRSG N/A
  • XLO N/A
  • Industry
  • TRSG
  • XLO Biotechnology: Pharmaceutical Preparations
  • Sector
  • TRSG
  • XLO Health Care
  • Exchange
  • TRSG NYSE
  • XLO Nasdaq
  • Market Cap
  • TRSG 33.4M
  • XLO 37.9M
  • IPO Year
  • TRSG 2024
  • XLO 2021
  • Fundamental
  • Price
  • TRSG $1.91
  • XLO $0.93
  • Analyst Decision
  • TRSG
  • XLO Buy
  • Analyst Count
  • TRSG 0
  • XLO 1
  • Target Price
  • TRSG N/A
  • XLO $4.00
  • AVG Volume (30 Days)
  • TRSG 2.9K
  • XLO 10.6M
  • Earning Date
  • TRSG 12-31-2024
  • XLO 03-31-2025
  • Dividend Yield
  • TRSG N/A
  • XLO N/A
  • EPS Growth
  • TRSG N/A
  • XLO N/A
  • EPS
  • TRSG N/A
  • XLO N/A
  • Revenue
  • TRSG $14,441,864.00
  • XLO $4,620,000.00
  • Revenue This Year
  • TRSG N/A
  • XLO N/A
  • Revenue Next Year
  • TRSG N/A
  • XLO $558.79
  • P/E Ratio
  • TRSG N/A
  • XLO N/A
  • Revenue Growth
  • TRSG 9.34
  • XLO N/A
  • 52 Week Low
  • TRSG $1.91
  • XLO $0.55
  • 52 Week High
  • TRSG $11.78
  • XLO $1.93
  • Technical
  • Relative Strength Index (RSI)
  • TRSG N/A
  • XLO 48.99
  • Support Level
  • TRSG N/A
  • XLO $0.97
  • Resistance Level
  • TRSG N/A
  • XLO $1.22
  • Average True Range (ATR)
  • TRSG 0.00
  • XLO 0.14
  • MACD
  • TRSG 0.00
  • XLO 0.03
  • Stochastic Oscillator
  • TRSG 0.00
  • XLO 28.04

About TRSG TUNGRAY TECHNOLOGIES INC

Tungray Technologies Inc is an engineer-to-order company that provides custom industrial manufacturing solutions to original equipment manufacturers in the semiconductor, printer, electronics, and home appliance industries. It predominantly generates revenue through the manufacture of custom industrial manufacturing solutions, direct drive and linear DC motors, and induction welding equipment. Geographically, the company generates a majority of its revenue from Singapore and the rest from China.

About XLO Xilio Therapeutics Inc.

Xilio Therapeutics Inc is a clinical-stage biotechnology company discovering and developing tumor-activated immuno-oncology (I-O) therapies with the goal of significantly improving outcomes for people living with cancer without the systemic side effects of current I-O treatments. The company is using its proprietary platform to advance a pipeline of novel, tumor-activated clinical and preclinical I-O molecules that are designed to optimize the therapeutic index by localizing anti-tumor activity within the tumor microenvironment, including tumor-activated cytokines and antibodies (including bispecifics) and immune cell engagers (including tumor-activated cell engagers and tumor-activated effector-enhanced cell engagers).

Share on Social Networks: